 |
|
Primary Therapy for Cushing's Disease With Metyrapone
Gabriel Dickstein, MD;
Michal Lahav, PhD;
Zila Shen-Orr, MS;
Yehuda Edoute, MD;
David Barzilai, MD
JAMA. 1986;255(9):1167-1169.
Abstract
A 13-year-old boy was diagnosed as suffering from pituitary-dependent Cushing's syndrome. He was treated with 2.0 g of metyrapone daily as the sole treatment for four years. All clinical and biochemical stigmata of Cushing's disease disappeared within a few months. The patient grew 23.0 cm in four years and regained normal health. No significant side effects of metyrapone were noticed. Administering the medication at 2 PM and 8 PM allowed higher cortisol levels in the morning and noon hours than in the evening and night, approximating the normal diurnal variation in cortisol production. We conclude that metyrapone may be considered the sole treatment in patients with Cushing's disease.
(JAMA 1986;255:1167-1169)
Author Affiliations
From the Endocrine Institute (Drs Dickstein and Barzilai and Ms Shen-Orr) and the Department of Internal Medicine C (Drs Edoute and Barzilai), Rambam Medical Center; and the Faculty of Medicine, Technion-Israel Institute of Technology (Drs Lahav and Barzilai), Haifa. Dr Dickstein is now with the Endocrine Institute, Haifa Medical Center (Rothschild), Israel.
Footnotes
Reprint requests to the Endocrine Institute, Haifa Medical Center (Rothschild), PO Box 4940, 31048 Haifa, Israel (Dr Dickstein).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Management of Endocrine Manifestations and the Use of Mitotane As a Chemotherapeutic Agent for Adrenocortical Carcinoma
Veytsman et al.
JCO 2009;27:4619-4629.
ABSTRACT
| FULL TEXT
Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease
Castinetti et al.
Eur J Endocrinol 2008;158:91-99.
ABSTRACT
| FULL TEXT
Spontaneous Remission in Cushing's Disease
Dickstein et al.
Arch Intern Med 1991;151:185-189.
ABSTRACT
|
